Shiga toxin binding in normal and inflamed human intestinal mucosa

Microbes and Infection

Volumn 9, Issue 1, 2007, Pages 35-39

  Schüller, Stephanie ^a   Heuschkel, Robert ^a   Torrente, Franco ^a   Kaper, James B ^b   Phillips, Alan D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

Human intestinal epithelium; Inflammation; Paneth cells; Shiga toxin; Shiga toxin producing E. coli

Indexed keywords

GB3 RECEPTOR; RECEPTOR; SHIGA TOXIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; ENTERITIS; GENE EXPRESSION; HEMOLYTIC UREMIC SYNDROME; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; LAMINA PROPRIA; PANETH CELL; PRIORITY JOURNAL;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PANETH CELLS; SHIGA-LIKE TOXIN I; SHIGA-LIKE TOXIN II;

EID: 33846451800     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.10.005     Document Type: Article

References (20)

1. Williams D.M., Sreedhar S.S., Mickell J.J., and Chan J.C.M. Acute kidney failure: a pediatric experience over 20 years. Arch. Pediatr. Adolesc. Med. 156 (2002) 893-900
2. Karmali M.A., Steele B.T., Petric M., and Lim C. Sporadic cases of haemolytic uremic syndrome associated with faecal cytotoxin and cytotoxin producing Escherichia coli in stools. Lancet 1 (1983) 619-620
3. Lindberg A.A., Brown J.E., Stromberg N., Westling-Ryd M., Schultz J.E., and Karlsson K.A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 262 (1987) 1779-1785
4. Lingwood C.A., Law H., Richardson S., Petric M., Brunton J.L., De Grandis S., and Karmali M. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262 (1987) 8834-8839
5. Hughes A.K., Ergonul Z., Stricklett P.K., and Kohan D.E. Molecular basis for high renal cell sensitivity to the cytotoxic effects of Shigatoxin-1: upregulation of globotriaosylceramide expression. J. Am. Soc. Nephrol. 13 (2002) 2239-2245
6. Schüller S., Frankel G., and Phillips A.D. Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture. Cell. Microbiol. 6 (2004) 289-301
7. Holgersson J., Jovall P.A., and Breimer M.E. Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J. Biochem. (Tokyo) 110 (1991) 120-131
8. Hughes A.K., Stricklett P.K., Schmid D., and Kohan D.E. Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int. 57 (2000) 2350-2359
9. Ramegowda B., Samuel J.E., and Tesh V.L. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J. Infect. Dis. 180 (1999) 1205-1213
10. van Setten P.A., Van Hinsbergh V.W., van der Velden T.J., van de Kar N.C., Vermeer M., Mahan J.D., Assmann K.J., van Den Heuvel L.P., and Monnens L.A. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int. 51 (1997) 1245-1256
11. Elphick D.A., and Mahida Y.R. Paneth cells: their role in innate immunity and inflammatory disease. Gut. 54 (2005) 1802-1809
12. Tanabe H., Ayabe T., Bainbridge B., Guina T., Ernst R.K., Darveau R.P., Miller S.I., and Ouellette A.J. Mouse Paneth cell secretory responses to cell surface glycolipids of virulent and attenuated pathogenic bacteria. Infect. Immun. 73 (2005) 2312-2320
13. Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., and Ouellette A.J. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1 (2000) 113-118
14. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., and Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7 (2001) 180-185
15. Jacewicz M.S., Acheson D.W., Mobassaleh M., Donohue-Rolfe A., Balasubramanian K.A., and Keusch G.T. Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. J. Clin. Invest. 96 (1995) 1328-1335
16. Mobassaleh M., Donohue-Rolfe A., Jacewicz M., Grand R.J., and Keusch G.T. Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine. J Infect. Dis. 157 (1988) 1023-1031
17. Ramegowda B., and Tesh V.L. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64 (1996) 1173-1180
18. Lingwood C.A. Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia. Biosci. Rep 19 (1999) 345-354
19. Kovbasnjuk O., Mourtazina R., Baibakov B., Wang T., Elowsky C., Choti M.A., Kane A., and Donowitz M. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc. Natl. Acad. Sci. U.S.A 102 (2005) 19087-19092
20. Westerholt S., Pieper A.K., Griebel M., Volk H.D., Hartung T., and Oberhoffer R. Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome. Clin. Diagn. Lab. Immunol. 10 (2003) 1090-1095